Daiwa Securities Group
AMRX icon

Daiwa Securities Group’s Amneal Pharmaceuticals AMRX Stock Holding History

Daiwa Securities Group’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-933
Closed -$12K – 1197
2025
Q4 		$12K Sell
933
-90
-9% -$1.03K ﹤0.01% 1176
2025
Q3 		$10K Hold
1,023
– – ﹤0.01% 1157
2025
Q2 		$8K Hold
1,023
– – ﹤0.01% 1125
2025
Q1 		$9K Hold
1,023
– – ﹤0.01% 1101
2024
Q4 		$8K Buy
+1,023
New +$8.58K ﹤0.01% 1129

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Daiwa Securities Group's AMRX Position: Q1 2026 in Review

Daiwa Securities Group sold out of Amneal Pharmaceuticals (AMRX) in Q1 2026, closing a stake of 933 shares — an estimated $12K sold.

Daiwa Securities Group first reported a position in AMRX in Q4 2024 and held it in 5 quarters. The position peaked at $12K in Q4 2025. 317 funds tracked by Wall St. Rank hold AMRX as of Q1 2026.

  • Daiwa Securities Group reported no remaining Amneal Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Daiwa Securities Group sold 933 Amneal Pharmaceuticals shares in Q1 2026, an estimated $12K.
  • Daiwa Securities Group first reported a position in Amneal Pharmaceuticals in Q4 2024 and held it in 5 quarters.
  • Daiwa Securities Group's Amneal Pharmaceuticals position peaked at $12K in Q4 2025.
  • 317 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q1 2026.

Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.